Bodybuilding Dietary Supplement Mayhem Recalled Due to Undeclared Drugs

A sports supplement company is voluntarily recalling its Mayhem dietary supplement capsules marketed to bodybuilders, after the FDA found 2 undeclared drugs in the product.

According to the FDA, the recalled yellow capsules associated with Lot #CLM061114 have an expiration date of June 2016 and contain undeclared dexamethasone, a prescription corticosteroid used to treat inflammatory conditions, and cyproheptadine, a prescription antihistamine used to treat seasonal allergies.

Corticosteroids like dexamethasone can hurt an individual’s ability to fight infections, raise blood sugar levels, and cause muscle injuries and psychiatric problems, the FDA said. The drug can also cause withdrawal symptoms if an individual stops taking them after prolonged use. In addition, the antihistamine that was found in the dietary supplement can cause drowsiness and affect mental alertness.

Thus, taking Mayhem supplements that contain those undeclared ingredients could cause adverse side effects when combined with other medications. However, the manufacturer, Chaotic Labz, has not yet heard of any adverse effects related to the recall.

The company is in the process of communicating the recall to its distributors and customers, and distribution of the product has been stopped.

The FDA is advising individuals to stop using Mayhem immediately and bring the product back to the place of its purchase. Health care professionals should be contacted if any adverse effects are experienced.

Customers with questions about the recall can contact the owner of Chaotic Labz, Cordy Hooten, at 479-223-2677 Monday through Friday from 9 a.m. to 5 p.m. Central Standard Time, or by email at contact.chaoticlabz@gmail.com.

Individuals who experienced an adverse reaction to the product can also report it to the FDA’s MedWatch by downloading a form at www.fda.gov/MedWatch/getforms.htm and submitting it online, or by requesting the form by phone at 1-800-332-1088 and mailing it in or submitting it via fax to 1-800-FDA-0178.